Mankind Pharma Limited

NSE: MANKIND · Healthcare · Lot size: 225

Mankind Pharma Limited Open Interest & PCR Analysis

2,332Updated 5 Jun 2026, 03:30 pm IST
PCR
0.43
Bearish signal
Max Pain
2,360
Spot below by ₹28
Total CE OI
892K
Call writers
Total PE OI
385K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-06-05

Frequently Asked Questions

What is Mankind Pharma Limited PCR (Put-Call Ratio) today?
Mankind Pharma Limited's current PCR is 0.43. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Mankind Pharma Limited's PCR of 0.43 indicates bearish sentiment.
What is Mankind Pharma Limited OI buildup type today?
Mankind Pharma Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Mankind Pharma Limited?
Mankind Pharma Limited has total CE (call) OI of 892350 contracts and total PE (put) OI of 384750 contracts for the nearest expiry. The PCR is 0.43.
How is open interest analysis useful for Mankind Pharma Limited trading?
OI analysis for Mankind Pharma Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Mankind Pharma Limited?
Mankind Pharma Limited's max pain is ₹2,360 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.